Analysis Version
v1
History
Back to Study: Statin use and dementia risk: A systematic review ...
correlational
Analysis v1
Strong Support

Taking rosuvastatin might lower the chance of getting dementia, more than other similar cholesterol drugs, based on several studies.

65
Pro
0
Against

Evidence from Studies

Supporting (1)

65

Community contributions welcome

65

Statin use and dementia risk: A systematic review and updated meta‐analysis

Systematic Review With Meta-Analysis
Human
2025 Jan-Mar

The study found that people who took rosuvastatin were 28% less likely to get dementia, which matches exactly what the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Statin use and dementia risk: A systematic review and updated meta‐analysis

Score: 65
DOI: 10.1002/trc2.70039

Similar Assertions

Taking rosuvastatin might help lower the chance of getting dementia, more than other similar cholesterol medicines.

65
0
98%

Taking statins might be linked to a lower chance of getting dementia, based on studies of millions of people — but we can't say for sure that statins are the reason why.

33
0
81%

Taking statins might help lower the chance of getting dementia, based on studies of millions of people — but we can't say for sure yet that statins are the reason.

65
0
80%

Taking statins might help lower the chance of getting dementia as you get older, according to a big look at past studies — but we can't say for sure that statins are the reason.

65
0
79%

Taking statins might help lower the chance of getting Alzheimer’s disease — studies show people on statins had about an 18% lower risk.

65
0
78%